Find Paid Clinical Trials in Oregon

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in Oregon

Top of Directory » All Locations » United States » Oregon




  • A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

    Condition:   Acne Vulgaris
    Interventions:   Drug: Tazarotene foam;   Drug: Vehicle Foam
    Sponsor:   Stiefel, a GSK Company
    Recruiting - verified November 2009

  • Genetic Analysis of PHACE Syndrome (Hemangioma With Other Congenital Anomalies)

    Condition:   PHACE Syndrome
    Intervention:  
    Sponsors:   Oregon Health and Science University;   Oregon Clinical and Translational Research Institute;   Society for Pediatric Dermatology
    Recruiting - verified November 2009

  • Study of HF10 in Patients With Refractory Head and Neck Cancer

    Condition:   Refractory Head and Neck Cancer
    Intervention:   Drug: HF10
    Sponsor:   M's Science Corporation
    Recruiting - verified November 2009

  • Multi-Site Evaluation of Progressive Tinnitus Management

    Condition:   Tinnitus
    Interventions:   Procedure: Progressive Tinnitus Management;   Procedure: Usual Care
    Sponsor:   Department of Veterans Affairs
    Not yet recruiting - verified November 2009

  • The Physical Effects of Pain Catastrophizing in Labor

    Condition:   Pregnancy
    Intervention:  
    Sponsor:   Oregon Health and Science University
    Recruiting - verified November 2009

  • Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer and Their First-Degree Relatives

    Condition:   Prostate Cancer
    Interventions:   Genetic: DNA analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: medical chart review;   Other: questionnaire administration;   Procedure: evaluation of cancer risk factors;   Procedure: study of high risk factors
    Sponsor:   Veterans Affairs Medical Center - Portland
    Recruiting - verified November 2009

  • A Phase IIb 78-week Study in Patients on a Basal Insulin +/- Metformin and/or Sulfonylurea and Are Not at Goal to Add BI 10773 vs. Placebo

    Condition:   Diabetes Mellitus, Type 2
    Intervention:   Drug: BI 10773
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified November 2009

  • BIBF 1120 or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer

    Conditions:   Ovarian Neoplasms;   Peritoneal Neoplasms
    Interventions:   Drug: BIBF 1120;   Drug: Placebo
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Not yet recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Pulmonary Disease, Chronic Obstructive
    Interventions:   Drug: GW642444 Inhalation Powder;   Drug: FF/GW642444 Inhalation Powder
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • Efficacy and Safety of Budesonide Foam for Patients With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis

    Conditions:   Proctitis;   Proctosigmoiditis
    Interventions:   Drug: Budesonide;   Drug: Placebo
    Sponsor:   Salix Pharmaceuticals
    Not yet recruiting - verified November 2009

  • The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • Baclofen to Reduce Alcohol Use in Veterans With HCV

    Conditions:   Hepatitis C;   Alcohol Use Disorders
    Interventions:   Drug: baclofen;   Drug: placebo
    Sponsor:   Department of Veterans Affairs
    Not yet recruiting - verified November 2009

  • Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • Treatment Trial Using Low Level Laser Therapy (LLLT) for Treatment of Chemotherapy Induced Peripheral Neuropathy

    Condition:   Peripheral Neuropathy
    Interventions:   Other: Low Level Laser;   Other: Placebo followed by Low Level Laser
    Sponsors:   Legacy Health System;   Legacy Health Foundation
    Recruiting - verified November 2009

  • A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents

    Condition:   Acute Migraine With or Without Aura
    Intervention:   Drug: rizatriptan benzoate
    Sponsor:   Merck
    Recruiting - verified November 2009

  • Natural History of Levodopa-Induced Dyskinesia (LID)

    Condition:   Parkinson's Disease
    Intervention:   Drug: Levodopa (delivered intravenously)
    Sponsors:   Oregon Health and Science University;   Oregon Clinical and Translational Research Institute
    Not yet recruiting - verified October 2009

  • Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)

    Conditions:   Graft-Versus-Host Disease;   Immune System Disorders
    Interventions:   Drug: Mycophenolate Mofetil;   Drug: Placebo
    Sponsors:   National Heart, Lung, and Blood Institute (NHLBI);   National Cancer Institute (NCI);   Blood and Marrow Transplant Clinical Trials Newtwork (BMT CTN)
    Not yet recruiting - verified October 2009

  • A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents

    Condition:   Acute Migraine With or Without Aura in Children and Adolescents.
    Interventions:   Drug: rizatriptan benzoate;   Drug: Comparator: Placebo
    Sponsor:   Merck
    Recruiting - verified November 2009

  • Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma

    Condition:   Lymphoma
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms

    Condition:   Major Depressive Disorder
    Interventions:   Drug: Duloxetine;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Not yet recruiting - verified November 2009

  • Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma

    Conditions:   Lymphoma;   Lymphoproliferative Disorder
    Interventions:   Other: biologic sample preservation procedure;   Other: informational intervention
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

    Conditions:   Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
    Interventions:   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI);   Eastern Cooperative Oncology Group
    Recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

    Condition:   Pregnancy Prevention
    Intervention:   Drug: DR-103
    Sponsor:   Teva Women's Health
    Recruiting - verified October 2009

  • Safety and Tolerability of TAK-491 Plus Chlorthalidone Compared to Olmesartan Medoxomil-Hydrochlorothiazide in Subjects With Essential Hypertension

    Condition:   Essential Hypertension
    Interventions:   Drug: TAK-491 and chlorthalidone;   Drug: Olmesartan medoxomil-hydrochlorothiazide
    Sponsor:   Takeda Global Research & Development Center, Inc.
    Recruiting - verified November 2009

  • A Weight Loss Study in Overweight Men and Women

    Condition:   Obesity
    Interventions:   Drug: LY377604;   Drug: Sibutramine;   Drug: Metoprolol XL;   Drug: Placebo sibutramine;   Drug: Placebo Metoprolol XL;   Drug: Placebo LY377604
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • A Study of LY573636 in Patients With Metastatic Breast Cancer

    Condition:   Breast Cancer
    Intervention:   Drug: LY573636
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Localized Alveolar Ridge Augmentation With Space Maintenance Devices

    Condition:   Alveolar Bone Loss
    Intervention:   Device: INFUSE® Bone Graft
    Sponsors:   Medtronic Spinal and Biologics;   Averion International Corporation
    Recruiting - verified October 2009

  • A Study of Advanced or Metastatic Non-small Cell Lung Cancer

    Condition:   Non Small Cell Lung Cancer
    Interventions:   Drug: LY2603618;   Drug: Pemetrexed
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Effects of the V1a Agonist FE 202158 in Patients With Septic Shock

    Condition:   Septic Shock
    Interventions:   Drug: FE 202158;   Drug: Sodium Chloride
    Sponsor:   Ferring Pharmaceuticals
    Not yet recruiting - verified October 2009

  • Long Term Safety and Efficacy Trial of Budesonide Dipropionate - Hydroflouroalkane (BDP-HFA) 320 Mcg in Allergic Rhinitis

    Condition:   Rhinitis, Allergic, Perennial
    Interventions:   Drug: BDP;   Drug: Placebo
    Sponsor:   Teva Global Respiratory Research LLC
    Recruiting - verified October 2009

  • A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment

    Condition:   Non-Hodgkin's Lymphoma
    Interventions:   Drug: YM155;   Biological: Rituximab
    Sponsor:   Astellas Pharma Inc
    Recruiting - verified November 2009

  • Nexavar® Versus Placebo in Locally Advance RAI-Refractory Differentiated Thyroid Cancer

    Condition:   Thyroid Neoplasm
    Interventions:   Drug: Nexavar (Sorafenib, BAY43-9006);   Drug: Placebo
    Sponsors:   Bayer;   Onyx
    Recruiting - verified November 2009

  • Dapagliflozin DPPIV Inhibitor add-on Study

    Condition:   Type 2 Diabetes
    Interventions:   Drug: Dapagliflozin;   Drug: Placebo
    Sponsors:   AstraZeneca;   Bristol-Myers Squibb
    Recruiting - verified November 2009

  • Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children

    Condition:   Influenza Infection
    Interventions:   Biological: GSK investigational vaccine GSK1557482A;   Biological: Fluzone®
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne

    Condition:   Severe Nodular Acne
    Intervention:   Drug: CIP-Isotretinoin and Isotretinoin
    Sponsor:   Cipher Pharmaceuticals Inc.
    Recruiting - verified November 2009

  • Efficacy and Safety Study of NBI-56418 Na in Subjects With Endometriosis

    Conditions:   Endometriosis;   Pain
    Interventions:   Drug: NBI-56418;   Drug: Placebo
    Sponsor:   Neurocrine Biosciences
    Recruiting - verified November 2009

  • Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone

    Condition:   Diabetes Mellitus, Type II
    Interventions:   Drug: Placebo;   Drug: Dutogliptin
    Sponsors:   Forest Laboratories;   Phenomix
    Recruiting - verified November 2009

  • Safety and Efficacy of F2695 SR in Major Depressive Disorder

    Condition:   Major Depressive Disorder
    Interventions:   Drug: F2695 SR;   Drug: F2695 SR;   Drug: F2695 SR;   Drug: Placebo
    Sponsor:   Forest Laboratories
    Recruiting - verified November 2009

  • A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder

    Condition:   Attention Deficit Hyperactivity Disorder
    Intervention:   Drug: LY2216684
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • A Study of RO5190591 in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1 Virus Infection

    Condition:   Hepatitis C, Chronic
    Interventions:   Drug: RO5190591;   Drug: RO5190591;   Drug: RO5190591;   Drug: RO5190591;   Drug: Placebo;   Drug: Placebo;   Drug: Pegasys;   Drug: Copegus
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • A Study in Relapse Prevention of Treatment-resistant Depression

    Condition:   Treatment Resistant Depression
    Interventions:   Drug: Olanzapine and Fluoxetine combination;   Drug: Fluoxetine
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • A Study of the Antiviral Activity, Safety, and Tolerability of Intravenous Peramivir in Adult and Adolescent Hospitalized Subjects With Confirmed or Suspected Influenza Infection

    Conditions:   Seasonal Influenza;   Cough;   Sore Throat;   Nasal Congestion;   Myalgia;   Headache;   Feverishness;   Fatigue
    Interventions:   Drug: Peramivir;   Drug: Peramivir
    Sponsors:   BioCryst Pharmaceuticals;   Department of Health and Human Services
    Recruiting - verified November 2009

  • Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B

    Condition:   Haemophilia B
    Interventions:   Drug: 40K PEG-rFIX;   Drug: 40K PEG-rFIX;   Drug: 40K PEG-rFIX
    Sponsor:   Novo Nordisk
    Recruiting - verified November 2009

  • Clinical Evaluation of the Storz CMAC Laryngoscope

    Conditions:   Intubation;   Airway Management
    Interventions:   Device: CMAC video laryngoscope;   Device: Macintosh laryngoscope
    Sponsor:   Oregon Health and Science University
    Recruiting - verified November 2009

  • Study to Investigate the Efficacy, Safety and Tolerability of AZD1152 Alone and in Combination With Low Dose Cytosine Arabinoside (LDAC)in Acute Myeloid Leukaemia (AML) Patients

    Condition:   Acute Myeloid Leukemia
    Interventions:   Drug: AZD1152;   Drug: LDAC;   Drug: AZD1152 + LDAC
    Sponsor:   AstraZeneca
    Recruiting - verified November 2009

  • COntrolled MyeloFibrosis Study With ORal JAK Inhibitor Treatment: The COMFORT-I Trial

    Condition:   Myelofibrosis
    Interventions:   Drug: INCB018424;   Drug: Placebo
    Sponsor:   Incyte Corporation
    Recruiting - verified November 2009

  • Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With Inhibitors

    Condition:   Haemophilia A or B With Inhibitors
    Interventions:   Drug: activated recombinant human factor VII, long acting;   Drug: activated recombinant human factor VII, long acting;   Drug: activated recombinant human factor VII, long acting
    Sponsor:   Novo Nordisk
    Recruiting - verified November 2009

  • Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

    Condition:   Lung Cancer
    Interventions:   Biological: bevacizumab;   Biological: cetuximab;   Drug: carboplatin;   Drug: paclitaxel
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A Study of the Safety and Efficacy of JNJ-39758979 in the Treatment of Adults With Asthma

    Condition:   Asthma
    Intervention:   Drug: JNJ39758979
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009

  • Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin

    Condition:   Diabetes Mellitus, Type II
    Interventions:   Drug: Dutogliptin;   Drug: Placebo
    Sponsors:   Forest Laboratories;   Phenomix
    Recruiting - verified October 2009

    • Menu
    Find Paid Clinical Trials